Precipio Schedules Q3-2023 Shareholder Update Call for November 20th

NEW HAVEN, Conn., Nov. 16, 2023 — Precipio, Inc. PRPO, a prominent player in the specialty cancer diagnostics sector, has announced its intention to conduct a corporate update call for the third quarter of 2023. The event, scheduled for November 20th, 2023, at 5:00 PM Eastern Time, will be an opportunity for the stakeholders and the wider investment community to receive comprehensive information regarding the company's latest developments and operational progress.

Corporate Update on Core Businesses

The upcoming shareholder call is anticipated to provide valuable insights into the performance and strategic trajectory of Precipio's core business areas. With its headquarters based in New Haven, Connecticut, Precipio specializes in the provision of diagnostic products and services, specifically catered to the oncology market within the United States. The company's emphasis on precision diagnostics is aimed at enhancing patient outcomes through the accurate detection and characterization of various cancer conditions.

About Precipio, Inc.

Founded with a mission to advance cancer care, Precipio, Inc. PRPO operates within the dynamic field of cancer diagnostics. Utilizing innovative reagent technology and diagnostic solutions, Precipio strives to address the critical needs of oncologists and their patients. The company's dedication to reliable, state-of-the-art cancer diagnostic techniques is reflected in its ongoing research and development efforts, and its commitment to quality is pivotal to its vision of becoming a key player in the cancer diagnostics landscape.

Precipio, Shareholder, Update